Cargando…
Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
Although vaccines and monoclonal antibody countermeasures have reduced the morbidity and mortality associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, variants with constellations of mutations in the spike gene jeopardize their efficacy. Accordingly, antiviral int...
Autores principales: | Chong, Zhenlu, Karl, Courtney E., Halfmann, Peter J., Kawaoka, Yoshihiro, Winkler, Emma S., Keeler, Shamus P., Holtzman, Michael J., Yu, Jinsheng, Diamond, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021357/ https://www.ncbi.nlm.nih.gov/pubmed/35523172 http://dx.doi.org/10.1016/j.celrep.2022.110799 |
Ejemplares similares
-
Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron
por: Chong, Zhenlu, et al.
Publicado: (2022) -
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
por: Lazear, Helen M., et al.
Publicado: (2015) -
Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010) -
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura, et al.
Publicado: (2021) -
Interferon-λ at the Center of the Storm
por: Hendricks, Matthew R., et al.
Publicado: (2020)